Jacob Plieth
Senior Reporter
Jacob has 21 years' experience of writing about healthcare, and joined Evaluate Vantage in 2012 from Edison Investment Research, where he spent five years as an equity research analyst.
He has also worked at Dow Jones and the Wall Street Journal. A biochemist by training, Jacob has spoken about pharmaceuticals and other topics on the BBC World Service and News 24, as well as contributing to various publications including Investors Chronicle and Mednous.
